Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The relationship between peripheral immune response and disease severity in SARS‐CoV‐2‐infected subjects: A cross‐sectional study
Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos‐Pirath, et al.
Immunology (2022) Vol. 165, Iss. 4, pp. 481-496
Open Access | Times Cited: 20

Showing 20 citing articles:

Functional reprogramming of monocytes in patients with acute and convalescent severe COVID-19
Elisa Brauns, Abdulkader Azouz, David Grimaldi, et al.
JCI Insight (2022) Vol. 7, Iss. 9
Open Access | Times Cited: 30
Severe COVID-19 is characterised by inflammation and immature myeloid cells early in disease progression
Liam Townsend, Adam H. Dyer, Aifric Naughton, et al.
Heliyon (2022) Vol. 8, Iss. 4, pp. e09230-e09230
Open Access | Times Cited: 25
Biomarkers Associated with Cardiovascular Disease in COVID-19
Christoph C. Kaufmann, Amro Ahmed, Achim Leo Burger, et al.
Cells (2022) Vol. 11, Iss. 6, pp. 922-922
Open Access | Times Cited: 22
Monocytic HLA-DR Expression in Immune Responses of Acute Pancreatitis and COVID-19
Shiyu Liu, Wenjuan Luo, Peter Szatmary, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3246-3246
Open Access | Times Cited: 14
The gut microbe pair of Oribacterium sp. GMB0313 and Ruminococcus sp. GMB0270 confers complete protection against SARS-CoV-2 infection by activating CD8+ T cell-mediated immunity
Mingda Wang, Enkhchimeg Lkhagva, Sura Kim, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 4
Moderate to severe SARS-CoV-2 infection primes vaccine-induced immunity more effectively than asymptomatic or mild infection
Kayla A. Holder, Danielle P. Ings, Debbie O. A. Harnum, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 15
Cellular Immune Responses to SARS-CoV-2 in Exposed Seronegative Individuals
Natasha J. Norton, Kayla A. Holder, Danielle P. Ings, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 996-996
Open Access | Times Cited: 7
T cell maturation is significantly affected by SARS‐CoV‐2 infection
Laura Otto Walter, Chandra Chiappin Cardoso, Íris Mattos Santos‐Pirath, et al.
Immunology (2023) Vol. 169, Iss. 3, pp. 358-368
Closed Access | Times Cited: 5
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients
Jéromine Klingler, Gregory S. Lambert, Juan C. Bandrés, et al.
iScience (2022) Vol. 25, Iss. 12, pp. 105608-105608
Open Access | Times Cited: 5
SARS-CoV-2-Induced Pathology—Relevance to COVID-19 Pathophysiology
Vsevolod Zinserling, N. Yu. Semenova, Anastasia E. Bikmurzina, et al.
Pathophysiology (2022) Vol. 29, Iss. 2, pp. 281-297
Open Access | Times Cited: 4
Lymphocyte B Subtypes in Peripheral Blood: A Prognostic Biomarker for COVID-19 Patients
Mariano Felisberto, Laura Otto Walter, Chandra Chiappin Cardoso, et al.
The Journal of Applied Laboratory Medicine (2024) Vol. 9, Iss. 3, pp. 456-467
Closed Access
Association of Monocyte Count With Lung Function and Exercise Capacity Among Hospitalized COVID‐19 Survivors: A 2‐Year Cohort Study
Xiaoying Gu, Lixue Huang, Xia Li, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 3
Open Access
Long-term changes in the phenotype and cytokine production of monocytes in COVID-19 recovered and vaccinated individuals
Yekaterina O. Ostapchuk, A. Lushova, Sofia A. Kan, et al.
Infection and Immunity (2024) Vol. 92, Iss. 7
Closed Access
Clinical, laboratory data and inflammatory biomarkers at baseline as early discharge predictors in hospitalized SARS-CoV-2 infected patients
María Trujillo‐Rodríguez, Esperanza Muñoz‐Muela, Ana Serna‐Gallego, et al.
PLoS ONE (2022) Vol. 17, Iss. 7, pp. e0269875-e0269875
Open Access | Times Cited: 3
Cytokine, Anti-SARS-CoV-2 Antibody, and Neutralizing Antibody Levels in Conventional Blood Donors Who Have Recovered from COVID-19
Elvira Maličev, Klemen Žiberna, Katerina Jazbec, et al.
Transfusion Medicine and Hemotherapy (2023) Vol. 51, Iss. 3, pp. 175-184
Open Access | Times Cited: 1
Antibody response and soluble mediator profile in the first six months following acute SARS-CoV-2 infection
Camila Amormino Corsini, Priscilla Soares Filgueiras, Nathalie Bonatti Franco Almeida, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access
IMMUNE PROFILES TO DISTINGUISH HOSPITALIZED VERSUS AMBULATORY COVID-19 CASES IN OLDER PATIENTS
Jéromine Klingler, Gregory S. Lambert, Juan C. Bandrés, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Immune Profiles to Distinguish Hospitalized Versus Ambulatory COVID-19 Cases in Older Patients
Jéromine Klingler, Gregory S. Lambert, Juan C. Bandrés, et al.
SSRN Electronic Journal (2022)
Open Access
COVİD-19 HASTALARININ RİSK SINIFLAMASINDA ENFLAMATUVAR İNDEKSLERİN PROGNOSTİK ROLÜ
Maide Alagöz, Ayşe Göker, Evin Ademoğlu
Sağlık Bilimlerinde İleri Araştırmalar Dergisi / Journal of Advanced Research in Health Sciences (2022)
Open Access
Page 1

Scroll to top